(S (S (VP (VBG Selecting) (NP (NP (DT the) (JJ right) (NNS drugs)) (PP (IN for) (NP (DT the) (JJ right) (NNS patients)))))) (VP (VBZ is) (NP (NP (DT a) (JJ primary) (NN goal)) (PP (IN of) (NP (NN precision) (NN medicine))))) (. .))
(S (PP (IN In) (NP (DT this) (NN manuscript))) (, ,) (NP (PRP we)) (VP (VBP consider) (NP (NP (DT the) (NN problem)) (PP (IN of) (NP (NML (NN cancer) (NN drug)) (NN selection)))) (PP (IN in) (NP (DT a) (NML (NN learning) (HYPH -) (IN to) (HYPH -) (NN rank)) (NN framework)))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN formulated) (NP (DT the) (NML (NN cancer) (NN drug)) (NN selection) (NN problem)) (PP (IN as) (IN to) (S (ADVP (RB accurately)) (VP (VBG predicting) (NP (CD 1))))) (-RRB- -RRB-))) (. .))
(FRAG (NP (NP (DT the) (VBG ranking) (NNS positions)) (PP (IN of) (NP (NP (JJ sensitive) (NNS drugs)) (CC and) (NP (CD 2)) (-RRB- -RRB-)))) (. .))
(S (NP (NP (DT the) (NN ranking) (NNS orders)) (PP (IN among) (NP (NP (JJ sensitive) (NNS drugs)) (PP (IN in) (NP (NML (NN cancer) (NN cell)) (NNS lines)))))) (VP (VBN based) (PP (IN on) (NP (PRP$ their) (NNS responses))) (PP (IN to) (NP (NN cancer) (NNS drugs)))) (. .))
(S (S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (JJ new) (NML (NN learning) (HYPH -) (IN to) (HYPH -) (NN rank)) (NN method)) (, ,) (VP (VBN denoted) (PP (IN as) (NP (NN pLETORg)))))))) (, ,) (NP (DT that)) (VP (VBZ predicts) (NP (NP (ADJP (NN drug) (VBG ranking)) (NNS structures)) (PP (IN in) (NP (DT each) (NML (NML (NML (NN cell) (NN line)) (PP (IN via) (S (VP (VBG using) (NP (NN drug) (NN latent) (NNS vectors)))))) (CC and) (NML (NN cell) (NN line))) (NN latent) (NNS vectors))))) (. .))
(S (S (NP (DT The) (NN pLETORg) (NN method)) (VP (VBZ learns) (NP (JJ such) (NN latent) (NNS vectors)) (PP (IN through) (S (ADVP (RB explicitly)) (VP (VBG enforcing) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NP (DT the) (NN drug) (NN ranking) (NN list)) (PP (IN of) (NP (DT each) (NN cell) (NN line))))) (, ,) (NP (DT the) (JJ sensitive) (NNS drugs)) (VP (VBP are) (VP (VBN pushed) (PP (IN above) (NP (JJ insensitive) (NNS drugs)))))))))))) (, ,) (CC and) (S (ADVP (RB meanwhile)) (NP (NP (DT the) (NN ranking) (NNS orders)) (PP (IN among) (NP (JJ sensitive) (NNS drugs)))) (VP (VBP are) (ADJP (JJ correct)))) (. .))
(S (NP (NP (NNP Genomics) (NN information)) (PP (IN on) (NP (NN cell) (NNS lines)))) (VP (VBZ is) (ADJP (VBN leveraged) (PP (IN in) (S (VP (VBG learning) (NP (DT the) (NN latent) (NNS vectors))))))) (. .))
(S (NP (NP (PRP$ Our) (JJ experimental) (NNS results)) (PP (IN on) (NP (DT a) (NN benchmark) (NN cell) (NML (NN line) (HYPH -) (NN drug)) (NN response) (NN dataset)))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT the) (JJ new) (NNP pLETORg)) (ADVP (RB significantly)) (VP (VBZ outperforms) (NP (DT the) (ADJP (NN state) (HYPH -) (IN of) (HYPH -) (DT the) (HYPH -) (NN art)) (NN method)) (PP (IN in) (S (VP (VBG prioritizing) (NP (JJ new) (JJ sensitive) (NNS drugs))))))))) (. .))
